Amarin Corp Plc (AMRN)

[sts66]

AMRN can't make their own GV - it's still called Vascepa, GV will be called icosapent ethyl - all AMRN can do is cut prices to match generics, but even that doesn't help in the states where generics are mandated. There was a bill passed by Congress in 2018 that forced pharmas to increase discounts for drugs sold while the patient is in the Medicare donut hole from 50% to 70%, but in states where generics must be given those Medicare patients actually pay more for the generic than the name brand - the law didn't force generics to reduce prices when patients hit the donut hole.